Could blocking a tiny artery in the head stop debilitating migraines?

NCT ID NCT06735833

Recruiting now Disease control Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing the safety and initial effectiveness of a minimally invasive procedure for adults with severe, treatment-resistant chronic migraines. The procedure involves injecting a medical glue-like substance into a specific artery in the head to block its blood flow. Researchers aim to see if this reduces the number of migraine days participants experience.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hartford Hospital
NOT_YET_RECRUITING

Hartford, Connecticut, 06032, United States
Mount Sinai
RECRUITING

New York, New York, 10029, United States
Semmes Murphey Foundation
RECRUITING

Memphis, Tennessee, 38120, United States
Stony Brook University Medical Center
RECRUITING

Stony Brook, New York, 11794, United States
Thomas Jefferson University Hospital
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
University of Buffalo Medical Center
NOT_YET_RECRUITING

Buffalo, New York, 14203, United States
West Virginia University
RECRUITING

Morgantown, West Virginia, 26506, United States

Conditions

Explore the condition pages connected to this study.

MIGRAINE